Regent Peak Wealth Advisors LLC increased its holdings in shares of Anthem, Inc. (NYSE:ANTM) by 3.1% during the first quarter, Holdings Channel.com reports. The fund owned 909 shares of the company’s stock after purchasing an additional 27 shares during the quarter. Regent Peak Wealth Advisors LLC’s holdings in Anthem were worth $326,000 as of its most recent filing with the SEC.
A number of other hedge funds have also recently added to or reduced their stakes in the business. Ascent Wealth Partners LLC lifted its position in shares of Anthem by 3.0% in the 1st quarter. Ascent Wealth Partners LLC now owns 963 shares of the company’s stock worth $346,000 after purchasing an additional 28 shares during the period. Park Avenue Securities LLC boosted its holdings in shares of Anthem by 0.8% in the 1st quarter. Park Avenue Securities LLC now owns 4,267 shares of the company’s stock worth $1,532,000 after buying an additional 33 shares during the last quarter. Pinnacle Financial Partners Inc. boosted its holdings in shares of Anthem by 2.0% in the 4th quarter. Pinnacle Financial Partners Inc. now owns 1,740 shares of the company’s stock worth $515,000 after buying an additional 34 shares during the last quarter. Chicago Capital LLC boosted its holdings in shares of Anthem by 1.8% in the 4th quarter. Chicago Capital LLC now owns 2,036 shares of the company’s stock worth $654,000 after buying an additional 36 shares during the last quarter. Finally, Brandywine Oak Private Wealth LLC lifted its holdings in Anthem by 4.0% during the fourth quarter. Brandywine Oak Private Wealth LLC now owns 940 shares of the company’s stock valued at $301,000 after purchasing an additional 36 shares during the last quarter. 89.36% of the stock is currently owned by hedge funds and other institutional investors.
Shares of NYSE ANTM traded up $4.51 during trading on Tuesday, reaching $391.09. The company had a trading volume of 25,871 shares, compared to its average volume of 1,298,946. Anthem, Inc. has a twelve month low of $244.10 and a twelve month high of $389.31. The stock has a market capitalization of $95.75 billion, a PE ratio of 20.11, a price-to-earnings-growth ratio of 0.92 and a beta of 1.00. The stock has a 50-day moving average price of $364.73 and a two-hundred day moving average price of $324.67. The company has a current ratio of 1.59, a quick ratio of 1.59 and a debt-to-equity ratio of 0.56.
The company also recently declared a quarterly dividend, which will be paid on Friday, June 25th. Shareholders of record on Thursday, June 10th will be given a dividend of $1.13 per share. This represents a $4.52 dividend on an annualized basis and a yield of 1.16%. The ex-dividend date is Wednesday, June 9th. This is an increase from Anthem’s previous quarterly dividend of $0.95. Anthem’s payout ratio is 23.25%.
In other Anthem news, EVP Peter D. Haytaian sold 59,500 shares of the stock in a transaction on Monday, March 22nd. The stock was sold at an average price of $349.20, for a total transaction of $20,777,400.00. Following the completion of the transaction, the executive vice president now directly owns 59,544 shares of the company’s stock, valued at approximately $20,792,764.80. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Ryan M. Schneider acquired 1,700 shares of the business’s stock in a transaction dated Thursday, February 4th. The shares were bought at an average price of $296.03 per share, with a total value of $503,251.00. Following the transaction, the director now directly owns 2,921 shares in the company, valued at approximately $864,703.63. The disclosure for this purchase can be found here. Insiders own 0.22% of the company’s stock.
A number of research firms have recently weighed in on ANTM. Royal Bank of Canada upped their target price on shares of Anthem from $350.00 to $399.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 28th. BMO Capital Markets raised their price target on Anthem from $440.00 to $450.00 and gave the stock an “outperform” rating in a research report on Thursday, April 22nd. Barclays raised their price target on Anthem from $375.00 to $425.00 and gave the stock an “overweight” rating in a research report on Wednesday, April 28th. Credit Suisse Group raised their price target on Anthem from $382.00 to $425.00 and gave the stock an “outperform” rating in a research report on Wednesday, April 28th. Finally, Jefferies Financial Group upgraded Anthem from a “hold” rating to a “buy” rating and lifted their price objective for the company from $305.00 to $402.00 in a report on Friday, January 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and sixteen have issued a buy rating to the stock. The company has an average rating of “Buy” and a consensus price target of $388.00.
Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.
Further Reading: Does the Step Transaction Doctrine Affect a Backdoor Roth IRA?
Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTM).
Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.